AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25510856 — intervention group
Group type: EXPERIMENTAL
Intervention: O‐desmethylvenlafaxine < 4 and venlafaxine + O‐desmethylvenlafaxine > 400 ng/ml
Number of subjects: 24
Study 22926014 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumour resection
Number of subjects: 216
Study 22926014 — intervention group
Group type: COMPARATOR
Intervention: No primary tumour resection
Number of subjects: 216
Study 21300298 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 450
Study 21300298 — intervention group
Group type: COMPARATOR
Intervention: CRT OFF
Number of subjects: 450
Study 19147401 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 24
Study 19147401 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 24
Study 19147401 — intervention group
Group type: COMPARATOR
Intervention: OSAS patients
Number of subjects: 24
Study 19147401 — intervention group
Group type: EXPERIMENTAL
Intervention: OSAS treatment (CPAP and MAD)
Number of subjects: 24
Study 16903598 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance-partitioned moxibustion at Guanyuan (CV 4) and Shenque (CV 8), once a day for 3 menstrual cycles
Number of subjects: 138
Study 16903598 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Yueyueshu Powder, twice a day, 10 g each time for 3 menstrual cycles
Number of subjects: 138
Study 15509188 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 0
Study 15509188 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 0
Study 15509188 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 0
Study 15509188 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 0
Study 15509188 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 0
Study 11393608 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination (EDE)
Number of subjects: 0
Study 11393608 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination Questionnaire (EDE-Q)
Number of subjects: 0
Study 11393608 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of eating behaviors
Number of subjects: 0
Study 11393608 — intervention group
Group type: EXPERIMENTAL
Intervention: EDE-Q and self-monitoring
Number of subjects: 0
Study 9251274 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTHIB vaccine given with primary immunization (age group 6 to 8 weeks) in 50 babies
Number of subjects: 172
Study 9251274 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTHIB vaccine
Number of subjects: 172
Study 8104070 — intervention group
Group type: COMPARATOR
Intervention: High-dose cyclophosphamide (HD-CY; 7 g/m2) alone
Number of subjects: 31
Study 8104070 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (HD-CY; 7 g/m2) with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; 5 micrograms/kg/day iv after HD-CY)
Number of subjects: 31
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose diet (36% sucrose) with low fiber
Number of subjects: 24
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose diet (52% sucrose) with low fiber
Number of subjects: 24
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose diet (36% sucrose) with high fiber
Number of subjects: 24
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose diet (52% sucrose) with high fiber
Number of subjects: 24
Study 3006471 — intervention group
Group type: COMPARATOR
Intervention: Low sucrose diets (0% and 18% sucrose)
Number of subjects: 24
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: All low fat diets
Number of subjects: 24
Study 3006471 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high carbohydrate diets with fiber
Number of subjects: 24
Study 31971832 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training (FT) (n = 14)
Number of subjects: 44
Study 31971832 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary Therapy (IT) (n = 19)
Number of subjects: 44
Study 31971832 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary Education (IE) (n = 11)
Number of subjects: 44
Study 31014313 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention to increase walking during the commute, implemented over 10 weeks with various behavioural change techniques.
Number of subjects: 654
Study 31014313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 654
Study 28489508 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 90
Study 28489508 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 90
Study 25927626 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected non-weight-bearing
Number of subjects: 0
Study 25927626 — intervention group
Group type: COMPARATOR
Intervention: Protected weight-bearing
Number of subjects: 0
Study 25927626 — intervention group
Group type: COMPARATOR
Intervention: Unprotected weight-bearing
Number of subjects: 0
Study 23014796 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR + Exercise (unilateral knee extensions at 30% of 1RM)
Number of subjects: 16
Study 23014796 — intervention group
Group type: COMPARATOR
Intervention: CON + Exercise (exercise without BFR)
Number of subjects: 16
Study 23014796 — intervention group
Group type: COMPARATOR
Intervention: BFR (rest with BFR applied)
Number of subjects: 16
Study 23014796 — intervention group
Group type: COMPARATOR
Intervention: CON (rest without treatment)
Number of subjects: 16
Study 23014796 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR + Exercise
Number of subjects: 16
Study 21574667 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 300
Study 19363237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerovit (1 capsule)
Number of subjects: 30
Study 19363237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerovit (2 capsules)
Number of subjects: 30
Study 19363237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17107542 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutta‐percha cones and AH 26 with smear layer (Group 1)
Number of subjects: 120
Study 17107542 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutta‐percha cones and AH 26 without smear layer (Group 2)
Number of subjects: 120
Study 17107542 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilon cones and Epiphany sealer without smear layer (Group 3)
Number of subjects: 120
Study 17107542 — intervention group
Group type: COMPARATOR
Intervention: Fluid transport model (all groups)
Number of subjects: 120
Study 12742986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA) measured by albumin cobalt binding (ACB) test after PCI
Number of subjects: 30
Study 12742986 — intervention group
Group type: COMPARATOR
Intervention: Ischemia modified albumin (IMA) in control group
Number of subjects: 30
Study 12742986 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-iso prostaglandin F2-A (iP) after PCI
Number of subjects: 30
Study 12742986 — intervention group
Group type: COMPARATOR
Intervention: 8-iso prostaglandin F2-A (iP) in control group
Number of subjects: 30
Study 10965289 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine and behavioral treatment
Number of subjects: 120
Study 10965289 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 120
Study 8857862 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 60% DMSO applied every 4 hours for 10 days after operation
Number of subjects: 51
Study 8857862 — intervention group
Group type: COMPARATOR
Intervention: Control group (operation alone)
Number of subjects: 51
Study 1536829 — intervention group
Group type: EXPERIMENTAL
Intervention: Two Gabor patches with different spatial frequencies identified in parallel when occupying the same spatial position.
Number of subjects: 0
Study 1536829 — intervention group
Group type: EXPERIMENTAL
Intervention: Two Gabor patches with the same spatial frequency identified in parallel even when separated by 8 degrees.
Number of subjects: 0
Study 1536829 — intervention group
Group type: EXPERIMENTAL
Intervention: Two Gabor patches with different spatial frequencies separated by 4 degrees or more.
Number of subjects: 0
Study 1536829 — intervention group
Group type: COMPARATOR
Intervention: Performance on double-task experiment compared to single-task performance.
Number of subjects: 0
Study 6369520 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose group (500 mg of tinidazole intravenously preoperatively)
Number of subjects: 588
Study 6369520 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day group (500 mg of tinidazole intravenously preoperatively + 3-day tinidazole treatment)
Number of subjects: 588
Study 6369520 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 588
Study 30696686 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent non-pharmacological delirium prevention intervention
Number of subjects: 40
Study 30696686 — intervention group
Group type: COMPARATOR
Intervention: Delirium screening and diagnostic assessment (Control)
Number of subjects: 40
Study 28525636 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement group (unimanual pattern of five sequential keystrokes)
Number of subjects: 20
Study 28525636 — intervention group
Group type: COMPARATOR
Intervention: Rest group (sat quietly without moving)
Number of subjects: 20
Study 28525636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 26701166 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 46
Study 26701166 — intervention group
Group type: COMPARATOR
Intervention: Routine perinatal care
Number of subjects: 46
Study 24705588 — intervention group
Group type: COMPARATOR
Intervention: PC1/3 activity in T2D patients
Number of subjects: 18
Study 24705588 — intervention group
Group type: COMPARATOR
Intervention: Intact proinsulin (IPI) levels in T2D patients
Number of subjects: 18
Study 24705588 — intervention group
Group type: COMPARATOR
Intervention: IPI/C-peptide ratio in T2D patients
Number of subjects: 18
Study 24705588 — intervention group
Group type: COMPARATOR
Intervention: C-peptide responses to glucagon in T2D patients
Number of subjects: 18
Study 24705588 — intervention group
Group type: COMPARATOR
Intervention: PC2 activity in T2D patients
Number of subjects: 18
Study 22659072 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4BN (Internet-based cognitive-behavioral therapy)
Number of subjects: 180
Study 22659072 — intervention group
Group type: COMPARATOR
Intervention: CBTF2F (traditional face-to-face cognitive-behavioral therapy)
Number of subjects: 180
Study 20491837 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic calcium phosphate (BCP)
Number of subjects: 11
Study 20491837 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone (DBB)
Number of subjects: 11
Study 18838638 — intervention group
Group type: COMPARATOR
Intervention: Medical management with placebo
Number of subjects: 1383
Study 18838638 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management plus naltrexone therapy
Number of subjects: 1383
Study 18838638 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management plus combined naltrexone and acamprosate therapy
Number of subjects: 1383
Study 15840994 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8% isoflurane
Number of subjects: 20
Study 15840994 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4% isoflurane
Number of subjects: 20
Study 15840994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanic stimulation of the ulnar nerve
Number of subjects: 20
Study 15840994 — intervention group
Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 20
Study 11859850 — intervention group
Group type: EXPERIMENTAL
Intervention: Second generation oral contraceptive (30 microg ethinylestradiol/150 microg levonorgestrel)
Number of subjects: 86
Study 11859850 — intervention group
Group type: EXPERIMENTAL
Intervention: Third generation oral contraceptive (30 microg ethinylestradiol/150 microg desogestrel)
Number of subjects: 86
Study 11859850 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel-containing preparations
Number of subjects: 86
Study 11859850 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestagen-only pills (150 microg desogestrel)
Number of subjects: 86
Study 11859850 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel-containing oral contraceptives
Number of subjects: 86
Study 11859850 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel-containing oral contraceptives
Number of subjects: 86
Study 10320115 — intervention group
Group type: EXPERIMENTAL
Intervention: Single question about mood
Number of subjects: 969
Study 10320115 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-item Center for Epidemiologic Studies Depression Screen
Number of subjects: 969
Study 10320115 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 969
Study 10320115 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-finding (both instruments combined)
Number of subjects: 969
Study 8704102 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange
Number of subjects: 0
Study 2061422 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% glycyrrhizin toothpaste
Number of subjects: 40
Study 2061422 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.50% glycyrrhizin toothpaste
Number of subjects: 40
Study 2061422 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste
Number of subjects: 40
Study 6367226 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 24
Study 6367226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 24
Study 6367226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31103498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% with fentanyl (RF)
Number of subjects: 94
Study 31103498 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.125% with fentanyl (BF)
Number of subjects: 94
Study 31103498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine/Fentanyl (RF)
Number of subjects: 94
Study 31103498 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine/Fentanyl (BF)
Number of subjects: 94
Study 29442177 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine plus MIRT
Number of subjects: 36
Study 29442177 — intervention group
Group type: COMPARATOR
Intervention: Rotigotine alone
Number of subjects: 36
Study 26962749 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care management intervention including Diabetes Self-care Management booklet, DVD viewing, counseling rehearsal session, and telephone follow-up
Number of subjects: 149
Study 26962749 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetic educational program (Control)
Number of subjects: 149
Study 23929692 — intervention group
Group type: EXPERIMENTAL
Intervention: Error Augmentation (EA) training
Number of subjects: 26
Study 23929692 — intervention group
Group type: COMPARATOR
Intervention: Simple repetitive practice (Control)
Number of subjects: 26
Study 21817123 — intervention group
Group type: EXPERIMENTAL
Intervention: Static magnetic stimulation (SMS) of the pelvic floor, 15 static magnets of 800-1200 Gauss, worn for at least 12 hours a day for 3 months
Number of subjects: 101
Study 21817123 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with inert metal disks, same protocol as SMS
Number of subjects: 101
Study 19346564 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D
Number of subjects: 394
Study 19346564 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-6D
Number of subjects: 394
Study 19346564 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EQ-5D and SF-6D
Number of subjects: 394
Study 17161670 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine
Number of subjects: 30
Study 17161670 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg famotidine
Number of subjects: 30
Study 17161670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg lafutidine b.d.
Number of subjects: 30
Study 15142209 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+500 mg of systemic tetracycline twice/day for 14 days
Number of subjects: 30
Study 15142209 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+tetracycline fibers (Actsite) at four selected sites for 10 days
Number of subjects: 30
Study 15142209 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 30
Study 10700052 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 5 mg
Number of subjects: 100
Study 10700052 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 5 mg
Number of subjects: 100
Study 10700052 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 10 mg
Number of subjects: 100
Study 9575643 — intervention group
Group type: EXPERIMENTAL
Intervention: Milgamma tablets (50 mg benfothiamine and 0.25 mg cyancobalamine)
Number of subjects: 45
Study 9575643 — intervention group
Group type: COMPARATOR
Intervention: Neurobex tablets
Number of subjects: 45
Study 8417806 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (400 to 1,500 U per kg twice daily [BID] per week)
Number of subjects: 9
Study 8417806 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (1,000 U/Kg, BID per week) with iron supplementation
Number of subjects: 9
Study 8417806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8417806 — intervention group
Group type: EXPERIMENTAL
Intervention: Open label rHuEPO administration
Number of subjects: 9
Study 8417806 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up on percent dense cell determinations
Number of subjects: 9
Study 2888547 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS 201-995 (50 micrograms)
Number of subjects: 5
Study 2888547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 2847454 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% glucose infusion with phosphate buffer (10 mmol phosphate buffer/l)
Number of subjects: 16
Study 2847454 — intervention group
Group type: COMPARATOR
Intervention: 10% glucose infusion without phosphate supplement
Number of subjects: 16
Study 31353479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of racemic carvedilol 25 mg (CAR)
Number of subjects: 16
Study 31353479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of racemic lercanidipine 20 mg (LER)
Number of subjects: 16
Study 31353479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral doses of CAR plus LER
Number of subjects: 16
Study 31353479 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal renal function)
Number of subjects: 16
Study 30032171 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred/intermittent ART
Number of subjects: 10156
Study 28791477 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 120
Study 28791477 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 120
Study 28791477 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane and Sevoflurane (both)
Number of subjects: 120
Study 26043025 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg po daily
Number of subjects: 30
Study 23602424 — intervention group
Group type: COMPARATOR
Intervention: Normal saline lavage (Group 1)
Number of subjects: 40
Study 23602424 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin solution lavage (Group 2)
Number of subjects: 40
Study 20541841 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day donepezil hydrochloride
Number of subjects: 0
Study 20541841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19104004 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus pravastatin
Number of subjects: 3277
Study 19104004 — intervention group
Group type: COMPARATOR
Intervention: Diet
Number of subjects: 3277
Study 16813139 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush T3 (Comfort Clean - Johnson & Johnson - Reach)
Number of subjects: 17
Study 16813139 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush T1 (Colgate Flexível - Colgate)
Number of subjects: 17
Study 16813139 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush T2 (Oral B Advantage Control Grip - Oral B)
Number of subjects: 17
Study 15334279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox shampoo
Number of subjects: 0
Study 10683004 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (specific movement sequence)
Number of subjects: 60
Study 10683004 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control group (non-specific movements)
Number of subjects: 60
Study 10683004 — intervention group
Group type: COMPARATOR
Intervention: Control group (no movements)
Number of subjects: 60
Study 9100160 — intervention group
Group type: COMPARATOR
Intervention: Libido (3 g twice daily)
Number of subjects: 31
Study 8468765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (250 mg every 6 hours for 3 days) followed by oral prednisone (1 mg/kg per day for 11 days)
Number of subjects: 457
Study 8468765 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (1 mg/kg per day for 14 days)
Number of subjects: 457
Study 8468765 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo for 14 days
Number of subjects: 457
Study 3963356 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg nalbuphine
Number of subjects: 7
Study 29461920 — intervention group
Group type: EXPERIMENTAL
Intervention: Creating Change (CC)
Number of subjects: 52
Study 29461920 — intervention group
Group type: COMPARATOR
Intervention: Seeking Safety (SS)
Number of subjects: 52
Study 25801662 — intervention group
Group type: EXPERIMENTAL
Intervention: Climate Schools course (Internet-based prevention program)
Number of subjects: 1103
Study 25801662 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education as usual)
Number of subjects: 1103
Study 24152821 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 61
Study 24152821 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 61